[1]
Ribas, A. et al. 1997. Frequent Dose Delays and Growth Factor Requirements with the Sequential Doxorubicin-CMF Schedule. Acta Oncologica. 36, 7 (Jan. 1997), 701–704. DOI:https://doi.org/10.3109/02841869709001340.